{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:27:36Z","timestamp":1794288456699,"version":"4.9.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Visceral Leishmaniasis (VL) is a fatal vector-borne parasitic disorder occurring mainly in tropical and subtropical regions. VL falls under the category of neglected tropical diseases with growing drug resistance and lacking a licensed vaccine. Conventional vaccine synthesis techniques are often very laborious and challenging. With the advancement of bioinformatics and its application in immunology, it is now more convenient to design multi-epitope vaccines comprising predicted immuno-dominant epitopes of multiple antigenic proteins. We have chosen four antigenic proteins of\u00a0<jats:italic>Leishmania donovani<\/jats:italic>\u00a0and identified their T-cell and B-cell epitopes, utilizing those for in-silico chimeric vaccine designing. The various physicochemical characteristics of the vaccine have been explored and the tertiary structure of the chimeric construct is predicted to perform docking studies and molecular dynamics simulations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The vaccine construct is generated by joining the epitopes with specific linkers. The predicted tertiary structure of the vaccine has been found to be valid and docking studies reveal the construct shows a high affinity towards the TLR-4 receptor. Population coverage analysis shows the vaccine can be effective on the majority of the world population.<jats:italic>In-silico<\/jats:italic>immune simulation studies confirms the vaccine to raise a pro-inflammatory response with the proliferation of activated T and B cells.<jats:italic>In-silico<\/jats:italic>codon optimization and cloning of the vaccine nucleic acid sequence have also been achieved in the pET28a vector.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The above bioinformatics data support that the construct may act as a potential vaccine. Further wet lab synthesis of the vaccine and in vivo works has to be undertaken in animal model to confirm vaccine potency.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12859-022-04816-6","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T07:03:39Z","timestamp":1659683019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["In-silico design of an immunoinformatics based multi-epitope vaccine against Leishmania donovani"],"prefix":"10.1186","volume":"23","author":[{"given":"Subhadip","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Vashishtha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishwajit","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monidipa","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"key":"4816_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/ijpvm.IJPVM_116_18","volume":"10","author":"M Moafi","year":"2019","unstructured":"Moafi M, Rezvan H, Sherkat R, et al. Leishmania vaccines entered in clinical trials: a review of literature. Int J Prev Med. 2019;10:95.","journal-title":"Int J Prev Med"},{"issue":"3","key":"4816_CR2","doi-asserted-by":"publisher","first-page":"e0004349","DOI":"10.1371\/journal.pntd.0004349","volume":"10","author":"M Akhoundi","year":"2016","unstructured":"Akhoundi M, Kuhls K, Cannet A, et al. A Historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies. PLoS Negl Trop Dis. 2016;10(3):e0004349.","journal-title":"PLoS Negl Trop Dis"},{"key":"4816_CR3","doi-asserted-by":"publisher","first-page":"750","DOI":"10.12688\/f1000research.11120.1","volume":"6","author":"E Torres-Guerrero","year":"2017","unstructured":"Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, et al. Leishmaniasis: a review. F1000Res. 2017;6:750.","journal-title":"F1000Res"},{"issue":"2","key":"4816_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40475-021-00232-7","volume":"8","author":"S Mann","year":"2021","unstructured":"Mann S, Frasca K, Scherrer S, et al. A review of Leishmaniasis: current knowledge and future directions. Curr Trop Med Rep. 2021;8(2):1\u201312.","journal-title":"Curr Trop Med Rep"},{"issue":"1","key":"4816_CR5","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S2666-5247(20)30166-X","volume":"2","author":"OP Singh","year":"2021","unstructured":"Singh OP, Tiwary P, Kushwaha AK, et al. Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study. Lancet Microbe. 2021;2(1):e23\u201331.","journal-title":"Lancet Microbe"},{"issue":"5","key":"4816_CR6","doi-asserted-by":"publisher","first-page":"35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C, et al. WHO Leishmaniasis control team Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE. 2012;7(5):35671.","journal-title":"PLoS ONE"},{"key":"4816_CR7","doi-asserted-by":"publisher","unstructured":"Wamai RG, Kahn J, McGloin J et al (2020) Visceral leishmaniasis: a global overview. J Glob Health Sci https:\/\/doi.org\/10.35500\/jghs.2020.2.e3.","DOI":"10.35500\/jghs.2020.2.e3"},{"issue":"7","key":"4816_CR8","doi-asserted-by":"publisher","first-page":"e2865","DOI":"10.1371\/journal.pntd.0002865","volume":"8","author":"PJ Hotez","year":"2014","unstructured":"Hotez PJ, Alvarado M, Bas\u00e1\u00f1ez MG, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis. 2014;8(7):e2865.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"4816_CR9","doi-asserted-by":"publisher","first-page":"8285","DOI":"10.1038\/s41598-017-08842-w","volume":"7","author":"N Khatoon","year":"2017","unstructured":"Khatoon N, Pandey RK, Prajapati VK. Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach. Sci Rep. 2017;7(1):8285.","journal-title":"Sci Rep"},{"issue":"12","key":"4816_CR10","doi-asserted-by":"publisher","first-page":"e1973","DOI":"10.1371\/journal.pntd.0001973","volume":"6","author":"A Stauch","year":"2012","unstructured":"Stauch A, Duerr HP, Dujardin JC, et al. Treatment of visceral Leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar India. PLoS Negl Trop Dis. 2012;6(12):e1973.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"4816_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/0974-777X.62886","volume":"2","author":"S Sundar","year":"2010","unstructured":"Sundar S, Chakravarty J. Liposomal amphotericin B and Leishmaniasis: dose and response. J Glob Infect Dis. 2010;2(2):159\u201366.","journal-title":"J Glob Infect Dis"},{"key":"4816_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40249-016-0112-2","volume":"5","author":"OP Singh","year":"2016","unstructured":"Singh OP, Singh B, Chakravarty J, et al. Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective. Infect Dis Poverty. 2016;5:19.","journal-title":"Infect Dis Poverty"},{"issue":"26","key":"4816_CR13","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","volume":"34","author":"PM Gillespie","year":"2016","unstructured":"Gillespie PM, Beaumier CM, Strych U, et al. Status of vaccine research and development of vaccines for Leishmaniasis. Vaccine. 2016;34(26):2992\u20135.","journal-title":"Vaccine"},{"issue":"6","key":"4816_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2174\/1566524043360203","volume":"4","author":"B Sukumaran","year":"2004","unstructured":"Sukumaran B, Madhubala R. Leishmaniasis: current status of vaccine development. Curr Mol Med. 2004;4(6):667\u201379.","journal-title":"Curr Mol Med"},{"issue":"Suppl","key":"4816_CR15","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1017\/S0031182006001831","volume":"133","author":"L Kedzierski","year":"2006","unstructured":"Kedzierski L, Zhu Y, Handman E. Leishmania vaccines: progress and problems. Parasitology. 2006;133(Suppl):S87-112.","journal-title":"Parasitology"},{"key":"4816_CR16","doi-asserted-by":"crossref","unstructured":"Kashif M, Hira SK, Manna PP. Immunoinformatics based design and prediction of proteome-wide killer cell epitopes of Leishmania donovani: potential application in vaccine development.\u00a0J Biomol Struct Dyn 2021:1\u201314.","DOI":"10.1080\/07391102.2021.1945495"},{"key":"4816_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2015.03.017","volume":"422","author":"K Jain","year":"2015","unstructured":"Jain K, Jain NK. Vaccines for visceral Leishmaniasis: a review. J Immunol Methods. 2015;422:1\u201312.","journal-title":"J Immunol Methods"},{"key":"4816_CR18","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1016\/j.vaccine.2011.02.096","volume":"29","author":"J Chakravarty","year":"2011","unstructured":"Chakravarty J, Kumar S, Trivedi S, et al. A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral Leishmaniasis. Vaccine. 2011;29:3531\u20137.","journal-title":"Vaccine"},{"key":"4816_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103704","volume":"136","author":"G Singh","year":"2019","unstructured":"Singh G, Pritam M, Banerjee M, et al. Genome based screening of epitope ensemble vaccine candidates against dreadful visceral Leishmaniasis using immunoinformatics approach. Microb Pathog. 2019;136: 103704.","journal-title":"Microb Pathog"},{"issue":"1","key":"4816_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.prevetmed.2014.06.015","volume":"117","author":"CE Wylie","year":"2014","unstructured":"Wylie CE, Carbonell-Anto\u00f1anzas M, Aiassa E, et al. Systematic review of the efficacy of prophylactic control measures for naturally-occurring canine Leishmaniosis, part I: vaccinations. Prev Vet Med. 2014;117(1):7\u201318.","journal-title":"Prev Vet Med"},{"issue":"7\u20138","key":"4816_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0264-410X(02)00566-2","volume":"21","author":"J Adu-Bobie","year":"2003","unstructured":"Adu-Bobie J, Capecchi B, Serruto D, et al. Two years into reverse vaccinology. Vaccine. 2003;21(7\u20138):605\u201310.","journal-title":"Vaccine"},{"issue":"1","key":"4816_CR22","doi-asserted-by":"publisher","first-page":"9044","DOI":"10.1038\/s41598-018-26689-7","volume":"8","author":"V Solanki","year":"2018","unstructured":"Solanki V, Tiwari V. Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii. Sci Rep. 2018;8(1):9044.","journal-title":"Sci Rep"},{"key":"4816_CR23","doi-asserted-by":"publisher","first-page":"104875","DOI":"10.1016\/j.meegid.2021.104875","volume":"92","author":"L Maharaj","year":"2021","unstructured":"Maharaj L, Adeleke VT, Fatoba AJ, et al. Immunoinformatics approach for multi-epitope vaccine design against P. Falciparum malaria. Infect Genet Evol. 2021;92:104875.","journal-title":"Infect Genet Evol"},{"issue":"9","key":"4816_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/14760584.2020.1811091","volume":"19","author":"SR Mahapatra","year":"2020","unstructured":"Mahapatra SR, Sahoo S, Dehury B, et al. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection. Expert Rev Vaccines. 2020;19(9):871\u201385.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"4816_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13071-020-04064-8","volume":"13","author":"MAA Khan","year":"2020","unstructured":"Khan MAA, Ami JQ, Faisal K, et al. An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes. Parasit Vectors. 2020;13(1):196.","journal-title":"Parasit Vectors"},{"issue":"8","key":"4816_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/20477724.2020.1842976","volume":"114","author":"S Yadav","year":"2020","unstructured":"Yadav S, Prakash J, Shukla H, et al. Design of a multi-epitope subunit vaccine for immune-protection against Leishmania parasite. Pathog Glob Health. 2020;114(8):471\u201381.","journal-title":"Pathog Glob Health"},{"issue":"2","key":"4816_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/vaccines8020252","volume":"8","author":"RCF Brito","year":"2020","unstructured":"Brito RCF, Ruiz JC, Cardoso JMO, et al. Chimeric vaccines designed by immunoinformatics-activated polyfunctional and memory T cells that trigger protection against experimental visceral Leishmaniasis. Vaccines. 2020;8(2):252.","journal-title":"Vaccines"},{"issue":"5","key":"4816_CR28","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1111\/j.1365-2958.2006.05459.x","volume":"62","author":"MM Kulkarni","year":"2006","unstructured":"Kulkarni MM, McMaster WR, Kamysz E, et al. The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing. Mol Microbiol. 2006;62(5):1484\u201397.","journal-title":"Mol Microbiol"},{"issue":"7","key":"4816_CR29","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.4049\/jimmunol.136.7.2613","volume":"136","author":"DG Russell","year":"1986","unstructured":"Russell DG, Wilhelm H. The involvement of the major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages. J Immunol. 1986;136(7):2613\u201320.","journal-title":"J Immunol"},{"issue":"12","key":"4816_CR30","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1128\/iai.64.12.5129-5137.1996","volume":"64","author":"MB Seay","year":"1996","unstructured":"Seay MB, Heard PL, Chaudhuri G. Surface Zn-proteinase as a molecule for defense of Leishmania Mexicana Amazonensis promastigotes against cytolysis inside macrophage phagolysosomes. Infect Immun. 1996;64(12):5129\u201337.","journal-title":"Infect Immun"},{"issue":"2","key":"4816_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-3024.2010.01253.x","volume":"33","author":"T Kaur","year":"2011","unstructured":"Kaur T, Sobti RC, Kaur S. Cocktail of gp63 and Hsp70 induces protection against Leishmania donovani in BALB\/c mice. Parasite Immunol. 2011;33(2):95\u2013103.","journal-title":"Parasite Immunol"},{"issue":"4","key":"4816_CR32","first-page":"582","volume":"78","author":"D Yang","year":"1993","unstructured":"Yang D, Rogers MV, Brett SJ, et al. Immunological analysis of the zinc-binding peptides of surface metalloproteinase (gp63) of Leishmania major. Immunology. 1993;78(4):582\u20135.","journal-title":"Immunology"},{"issue":"3","key":"4816_CR33","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1128\/IAI.00611-07","volume":"76","author":"S Bhowmick","year":"2008","unstructured":"Bhowmick S, Ravindran R, Ali N. gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB\/c mice infected with Leishmania donovani. Infect Immun. 2008;76(3):1003\u201315.","journal-title":"Infect Immun"},{"key":"4816_CR34","doi-asserted-by":"crossref","unstructured":"Shen B, Buguliskis JS, Lee TD et al (2014) Functional analysis of rhomboid proteases during Toxoplasma invasion. mBio 5(5): 01795\u201314.","DOI":"10.1128\/mBio.01795-14"},{"issue":"1","key":"4816_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12879-016-2104-z","volume":"17","author":"Y Han","year":"2017","unstructured":"Han Y, Zhou A, Lu G, et al. Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB\/c mice. BMC Infect Dis. 2017;17(1):59.","journal-title":"BMC Infect Dis"},{"issue":"2\u20134","key":"4816_CR36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.vetpar.2011.08.014","volume":"184","author":"J Li","year":"2012","unstructured":"Li J, Han Q, Gong P, et al. Toxoplasma gondii rhomboid protein 1 (TgROM1) is a potential vaccine candidate against toxoplasmosis. Vet Parasitol. 2012;184(2\u20134):154\u201360.","journal-title":"Vet Parasitol"},{"key":"4816_CR37","doi-asserted-by":"crossref","unstructured":"Biswas B, Laha B, Ghosh M. Characterization of a novel amastin-like surface protein (ALSP) of Leishmania donovani, a probable lipase.\u00a0bioRxiv. Published online 2020:2020.07.23.218107.","DOI":"10.1101\/2020.07.23.218107"},{"issue":"3","key":"4816_CR38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0014-4894(85)90039-6","volume":"60","author":"AT Remaley","year":"1985","unstructured":"Remaley AT, Glew RH, Kuhns DB, et al. Leishmania donovani: surface membrane acid phosphatase blocks neutrophil oxidative metabolite production. Exp Parasitol. 1985;60(3):331\u201341.","journal-title":"Exp Parasitol"},{"issue":"3","key":"4816_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1574-6968.1992.tb05322.x","volume":"94","author":"N Singla","year":"1992","unstructured":"Singla N, Khuller GK, Vinayak VK. Acid phosphatase activity of promastigotes of Leishmania donovani: a marker of virulence. FEMS Microbiol Lett. 1992;94(3):221\u20135.","journal-title":"FEMS Microbiol Lett"},{"issue":"3","key":"4816_CR40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1042\/BJ20141371","volume":"467","author":"A Papadaki","year":"2015","unstructured":"Papadaki A, Politou AS, Smirlis D, et al. The Leishmania donovani histidine acid ecto-phosphatase LdMAcP: insight into its structure and function. Biochem J. 2015;467(3):473\u201386.","journal-title":"Biochem J"},{"issue":"1","key":"4816_CR41","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1038\/s41598-019-39299-8","volume":"9","author":"V Chauhan","year":"2019","unstructured":"Chauhan V, Rungta T, Goyal K, et al. Designing a multi-epitope based vaccine to combat Kaposi Sarcoma utilizing immunoinformatics approach. Sci Rep. 2019;9(1):2517.","journal-title":"Sci Rep"},{"issue":"2","key":"4816_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/0974-777X.62883","volume":"2","author":"EM Moore","year":"2010","unstructured":"Moore EM, Lockwood DN. Treatment of visceral Leishmaniasis. J Glob Infect Dis. 2010;2(2):151\u20138.","journal-title":"J Glob Infect Dis"},{"issue":"6","key":"4816_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3390\/vaccines9060669","volume":"9","author":"MA Soltan","year":"2021","unstructured":"Soltan MA, Elbassiouny N, Gamal H, et al. In silico prediction of a multitope vaccine against Moraxella catarrhalis: reverse vaccinology and immunoinformatics. Vaccines. 2021;9(6):669.","journal-title":"Vaccines"},{"issue":"2","key":"4816_CR44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.virol.2010.12.016","volume":"411","author":"IJ Amanna","year":"2011","unstructured":"Amanna IJ, Slifka MK. Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology. 2011;411(2):206\u201315.","journal-title":"Virology"},{"issue":"8","key":"4816_CR45","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","volume":"168","author":"Y Belkaid","year":"2002","unstructured":"Belkaid Y, Von Stebut E, Mendez S, et al. CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major. J Immunol. 2002;168(8):3992\u20134000.","journal-title":"J Immunol"},{"issue":"1","key":"4816_CR46","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1128\/IAI.74.1.773-776.2006","volume":"74","author":"R Polley","year":"2006","unstructured":"Polley R, Stager S, Prickett S, et al. Adoptive immunotherapy against experimental visceral Leishmaniasis with CD8+ T cells requires the presence of cognate antigen. Infect Immun. 2006;74(1):773\u20136.","journal-title":"Infect Immun"},{"issue":"1","key":"4816_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/icb.1983.2","volume":"61","author":"GF Mitchell","year":"1983","unstructured":"Mitchell GF, Handman E. Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility. Aust J Exp Biol Med Sci. 1983;61(1):11\u201325.","journal-title":"Aust J Exp Biol Med Sci"},{"issue":"1","key":"4816_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1084\/jem.20052288","volume":"203","author":"F Woelbing","year":"2006","unstructured":"Woelbing F, Kostka SL, Moelle K, et al. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med. 2006;203(1):177\u201388.","journal-title":"J Exp Med"},{"issue":"3","key":"4816_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10989-021-10218-8","volume":"27","author":"A Atapour","year":"2021","unstructured":"Atapour A, Ghalamfarsa F, Naderi S, et al. Designing of a novel fusion protein vaccine candidate against human visceral Leishmaniasis (VL) using immunoinformatics and structural approaches. Int J Pept Res Ther. 2021;27(3):1\u201314.","journal-title":"Int J Pept Res Ther"},{"issue":"8","key":"4816_CR50","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/microorganisms8081201","volume":"8","author":"NM Ikeogu","year":"2020","unstructured":"Ikeogu NM, Akaluka GN, Edechi CA, et al. Leishmania immunity: advancing immunotherapy and vaccine development. Microorganisms. 2020;8(8):1201.","journal-title":"Microorganisms"},{"issue":"1","key":"4816_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007;8(1):4.","journal-title":"BMC Bioinformatics"},{"key":"4816_CR52","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/B978-0-12-815876-0.00032-2","volume-title":"Chronic Renal Disease","author":"MV Pahl","year":"2020","unstructured":"Pahl MV, Vaziri ND. Immune function in chronic kidney disease. In: Kimmel PL, Rosenberg ME, editors. Chronic Renal Disease. Elsevier; 2020. p. 503\u201319."},{"key":"4816_CR53","unstructured":"Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P.\u00a0Molecular biology of the cell. 4th ed. (Alberts B, etc., eds.). CRC Press; 2002."},{"issue":"3","key":"4816_CR54","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/tan.13956","volume":"96","author":"R Barquera","year":"2020","unstructured":"Barquera R, Collen E, Di D, et al. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide. HLA. 2020;96(3):277\u201398.","journal-title":"HLA"},{"issue":"9","key":"4816_CR55","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/14760584.2020.1813576","volume":"19","author":"A Kumar","year":"2020","unstructured":"Kumar A, Kumar P, Saumya KU, et al. Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach. Expert Rev Vaccines. 2020;19(9):887\u201398.","journal-title":"Expert Rev Vaccines"},{"key":"4816_CR56","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1745-6150-8-30","volume":"8","author":"SK Dhanda","year":"2013","unstructured":"Dhanda SK, Vir P, Raghava GP. Designing of interferon-gamma inducing MHC class-II binders. Biol Direct. 2013;8:30.","journal-title":"Biol Direct"},{"issue":"1","key":"4816_CR57","doi-asserted-by":"publisher","first-page":"42851","DOI":"10.1038\/srep42851","volume":"7","author":"G Nagpal","year":"2017","unstructured":"Nagpal G, Usmani SS, Dhanda SK, et al. Computer-aided designing of immunosuppressive peptides based on IL-10 inducing potential. Sci Rep. 2017;7(1):42851.","journal-title":"Sci Rep"},{"issue":"1","key":"4816_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169496","volume":"12","author":"AA Medina-Colorado","year":"2017","unstructured":"Medina-Colorado AA, Osorio EY, Saldarriaga OA, et al. Splenic CD4+ T cells in progressive visceral Leishmaniasis show a mixed effector-regulatory phenotype and impair macrophage effector function through inhibitory receptor expression. PLoS ONE. 2017;12(1): e0169496.","journal-title":"PLoS ONE"},{"issue":"7","key":"4816_CR59","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.4049\/jimmunol.1003588","volume":"186","author":"NA Ansari","year":"2011","unstructured":"Ansari NA, Kumar R, Gautam S, et al. IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J Immunol. 2011;186(7):3977\u201385.","journal-title":"J Immunol"},{"issue":"10","key":"4816_CR60","doi-asserted-by":"publisher","first-page":"e3198","DOI":"10.1371\/journal.pntd.0003198","volume":"8","author":"R Kumar","year":"2014","unstructured":"Kumar R, Singh N, Gautam S, et al. Leishmania specific CD4 T cells release IFN\u03b3 that limits parasite replication in patients with visceral leishmaniasis. PLoS Negl Trop Dis. 2014;8(10):e3198.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"4816_CR61","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13071-016-1412-x","volume":"9","author":"V Rodrigues","year":"2016","unstructured":"Rodrigues V, Cordeiro-da-Silva A, Laforge M, et al. Regulation of immunity during visceral Leishmania infection. Parasit Vectors. 2016;9(1):118.","journal-title":"Parasit Vectors"},{"issue":"3","key":"4816_CR62","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/imm.12889","volume":"154","author":"KK Jensen","year":"2018","unstructured":"Jensen KK, Andreatta M, Marcatili P, et al. Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology. 2018;154(3):394\u2013406.","journal-title":"Immunology"},{"key":"4816_CR63","doi-asserted-by":"crossref","unstructured":"Vijayamahantesh, Amit A, Dikhit MR, et al. Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral Leishmaniasis subjects.\u00a0Microbes Infect 2017;19(6):358\u2013369.","DOI":"10.1016\/j.micinf.2017.03.002"},{"issue":"1","key":"4816_CR64","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1186\/s12879-014-0653-6","volume":"14","author":"H Kaushal","year":"2014","unstructured":"Kaushal H, Bras-Gon\u00e7alves R, Negi NS, et al. Role of CD8(+) T cells in protection against Leishmania donovani infection in healed visceral Leishmaniasis individuals. BMC Infect Dis. 2014;14(1):653.","journal-title":"BMC Infect Dis"},{"key":"4816_CR65","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/1471-2105-8-424","volume":"8","author":"MV Larsen","year":"2007","unstructured":"Larsen MV, Lundegaard C, Lamberth K, et al. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics. 2007;8:424.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"4816_CR66","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","volume":"32","author":"M Andreatta","year":"2016","unstructured":"Andreatta M, Nielsen M. Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics. 2016;32(4):511\u20137.","journal-title":"Bioinformatics"},{"issue":"1","key":"4816_CR67","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/prot.21078","volume":"65","author":"S Saha","year":"2006","unstructured":"Saha S, Raghava GPS. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins. 2006;65(1):40\u20138.","journal-title":"Proteins"},{"issue":"42","key":"4816_CR68","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1016\/j.vaccine.2021.09.025","volume":"39","author":"SR Mahapatra","year":"2021","unstructured":"Mahapatra SR, Dey J, Kaur T, et al. Immunoinformatics and molecular docking studies reveal a novel multi-Epitope peptide vaccine against pneumonia infection. Vaccine. 2021;39(42):6221\u201337.","journal-title":"Vaccine"},{"key":"4816_CR69","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3389\/fimmu.2020.01784","volume":"11","author":"R Dong","year":"2020","unstructured":"Dong R, Chu Z, Yu F, et al. Contriving multi-Epitope subunit of vaccine for COVID-19: Immunoinformatics approaches. Front Immunol. 2020;11:1784.","journal-title":"Front Immunol"},{"issue":"30","key":"4816_CR70","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1016\/j.vaccine.2018.05.082","volume":"36","author":"RK Pandey","year":"2018","unstructured":"Pandey RK, Ali M, Ojha R, et al. Development of multi-epitope driven subunit vaccine in secretory and membrane protein of Plasmodium falciparum to convey protection against malaria infection. Vaccine. 2018;36(30):4555\u201365.","journal-title":"Vaccine"},{"issue":"1","key":"4816_CR71","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1038\/s41598-019-40833-x","volume":"9","author":"RA Shey","year":"2019","unstructured":"Shey RA, Ghogomu SM, Esoh KK, et al. In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases. Sci Rep. 2019;9(1):4409.","journal-title":"Sci Rep"},{"issue":"1","key":"4816_CR72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1365-2443.1997.1020301.x","volume":"2","author":"A Varshavsky","year":"1997","unstructured":"Varshavsky A. The N-end rule pathway of protein degradation. Genes Cells. 1997;2(1):13\u201328.","journal-title":"Genes Cells"},{"issue":"6","key":"4816_CR73","first-page":"1895","volume":"88","author":"A Ikai","year":"1980","unstructured":"Ikai A. Thermostability and aliphatic index of globular proteins. J Biochem. 1980;88(6):1895\u20138.","journal-title":"J Biochem"},{"issue":"5","key":"4816_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036968","volume":"7","author":"E Jaspard","year":"2012","unstructured":"Jaspard E, Macherel D, Hunault G. Computational and statistical analyses of amino acid usage and physico-chemical properties of the twelve late embryogenesis abundant protein classes. PLoS ONE. 2012;7(5): e36968.","journal-title":"PLoS ONE"},{"issue":"3","key":"4816_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.151955","volume":"225","author":"B Sarkar","year":"2020","unstructured":"Sarkar B, Ullah MA, Johora FT, et al. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2). Immunobiology. 2020;225(3): 151955.","journal-title":"Immunobiology"},{"key":"4816_CR76","unstructured":"Gupta R, Brunak S. Prediction of glycosylation across the human proteome and the correlation to protein function. Pac Symp Biocomput. 2002;310\u201322."},{"issue":"1","key":"4816_CR77","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/1471-2105-8-361","volume":"8","author":"HH Bui","year":"2007","unstructured":"Bui HH, Sidney J, Li W, et al. Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinformatics. 2007;8(1):361.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"4816_CR78","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-7-153","volume":"7","author":"HH Bui","year":"2006","unstructured":"Bui HH, Sidney J, Dinh K, et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics. 2006;7(1):153.","journal-title":"BMC Bioinformatics"},{"key":"4816_CR79","doi-asserted-by":"crossref","unstructured":"Dimitrov I, Flower DR, Doytchinova I. AllerTOP--a server for in silico prediction of allergens.\u00a0BMC Bioinformatics 2013;14 Suppl 6(S6):S4.","DOI":"10.1186\/1471-2105-14-S6-S4"},{"issue":"4","key":"4816_CR80","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","volume":"16","author":"LJ McGuffin","year":"2000","unstructured":"McGuffin LJ, Bryson K, Jones DT. The PSIPRED protein structure prediction server. Bioinformatics. 2000;16(4):404\u20135.","journal-title":"Bioinformatics"},{"issue":"34","key":"4816_CR81","doi-asserted-by":"publisher","first-page":"16856","DOI":"10.1073\/pnas.1821309116","volume":"116","author":"J Xu","year":"2019","unstructured":"Xu J. Distance-based protein folding powered by deep learning. Proc Natl Acad Sci U S A. 2019;116(34):16856\u201365.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4816_CR82","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/nar\/gkt458","volume":"41","author":"L Heo","year":"2013","unstructured":"Heo L, Park H, Seok C. GalaxyRefine: protein structure refinement driven by side-chain repacking. Nucleic Acids Res. 2013;41:384\u20138.","journal-title":"Nucleic Acids Res"},{"key":"4816_CR83","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1038\/s41598-021-81749-9","volume":"11","author":"Z Yang","year":"2021","unstructured":"Yang Z, Bogdan P, Nazarian S. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study. Sci Rep. 2021;11:3238.","journal-title":"Sci Rep"},{"key":"4816_CR84","doi-asserted-by":"crossref","unstructured":"Ayyagari VS, T C V, K AP, et al. Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: an immunoinformatics approach. J Biomol Struct Dyn. Published online 2020:1\u201315.","DOI":"10.1080\/07391102.2020.1850357"},{"issue":"W1","key":"4816_CR85","doi-asserted-by":"publisher","first-page":"W338","DOI":"10.1093\/nar\/gky356","volume":"46","author":"A Kuriata","year":"2018","unstructured":"Kuriata A, Gierut AM, Oleniecki T, et al. CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures. Nucleic Acids Res. 2018;46(W1):W338\u201343.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"4816_CR86","doi-asserted-by":"publisher","first-page":"e0119264","DOI":"10.1371\/journal.pone.0119264","volume":"10","author":"L Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez L. Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis. PLoS ONE. 2015;10(3):e0119264.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"4816_CR87","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molimm.2012.06.001","volume":"53","author":"JV Kringelum","year":"2013","unstructured":"Kringelum JV, Nielsen M, Padkj\u00e6r SB, et al. Structural analysis of B-cell epitopes in antibody:protein complexes. Mol Immunol. 2013;53(1\u20132):24\u201334.","journal-title":"Mol Immunol"},{"issue":"1","key":"4816_CR88","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko J, Bui H-H, Li W, et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics. 2008;9(1):514.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"4816_CR89","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s41598-020-80899-6","volume":"11","author":"S Bibi","year":"2021","unstructured":"Bibi S, Ullah I, Zhu B, et al. In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology. Sci Rep. 2021;11(1):1249.","journal-title":"Sci Rep"},{"issue":"2","key":"4816_CR90","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/jcb.26719","volume":"120","author":"RK Pandey","year":"2018","unstructured":"Pandey RK, Prajapati VK. Exploring sand fly salivary proteins to design multi-epitope subunit vaccine to fight against visceral Leishmaniasis. J Cell Biochem. 2018;120(2):1141\u201355.","journal-title":"J Cell Biochem"},{"issue":"4","key":"4816_CR91","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1128\/IAI.72.4.1920-1928.2004","volume":"72","author":"P Kropf","year":"2004","unstructured":"Kropf P, Freudenberg MA, Modolell M, et al. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect Immun. 2004;72(4):1920\u20138.","journal-title":"Infect Immun"},{"issue":"7","key":"4816_CR92","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1128\/IAI.01468-12","volume":"81","author":"HW Murray","year":"2013","unstructured":"Murray HW, Zhang Y, Zhang Y, et al. Regulatory actions of toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver. Infect Immun. 2013;81(7):2318\u201326.","journal-title":"Infect Immun"},{"issue":"2","key":"4816_CR93","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, et al. The ClusPro web server for protein-protein docking. Nat Protoc. 2017;12(2):255-278.","journal-title":"Nat Protoc."},{"issue":"23","key":"4816_CR94","doi-asserted-by":"publisher","first-page":"btw514","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"LC Xue","year":"2016","unstructured":"Xue LC, Rodrigues JP, Kastritis PL, et al. PRODIGY: a web server for predicting the binding affinity of protein\u2013protein complexes. Bioinformatics. 2016;32(23):btw514.","journal-title":"Bioinformatics"},{"issue":"4","key":"4816_CR95","first-page":"e9862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin N, Lund O, Bernaschi M, et al. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One. 2010;5(4):e9862.","journal-title":"Bioinformatics"},{"key":"4816_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.621706","volume":"12","author":"RCO Sanches","year":"2021","unstructured":"Sanches RCO, Tiwari S, Ferreira LCG, et al. Immunoinformatics design of multi-Epitope peptide-based vaccine against Schistosoma mansoni using transmembrane proteins as a target. Front Immunol. 2021;12: 621706.","journal-title":"Front Immunol"},{"issue":"3","key":"4816_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248061","volume":"16","author":"OS Chukwudozie","year":"2021","unstructured":"Chukwudozie OS, Gray CM, Fagbayi TA, et al. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein. PLoS ONE. 2021;16(3): e0248061.","journal-title":"PLoS ONE"},{"issue":"9","key":"4816_CR98","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/jcc.21773","volume":"32","author":"MJ Abraham","year":"2011","unstructured":"Abraham MJ, Gready JE. Optimisation of parameters for molecular dynamics simulation using smooth particle-mesh Ewald in GROMACS 4.5. J Comput Chem. 2011;32(9):2031\u201340.","journal-title":"J Comput Chem"},{"issue":"7","key":"4816_CR99","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","volume":"29","author":"S Pronk","year":"2013","unstructured":"Pronk S, P\u00e1ll S, Schulz R, et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics. 2013;29(7):845\u201354.","journal-title":"Bioinformatics"},{"issue":"16","key":"4816_CR100","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B, et al. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26(16):1701\u201318.","journal-title":"J Comput Chem"},{"key":"4816_CR101","doi-asserted-by":"crossref","unstructured":"Kumari R, Kumar R, Open Source Drug Discovery Consortium, et al. g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations.\u00a0J Chem Inf Model. 2014;54(7):1951\u20131962.","DOI":"10.1021\/ci500020m"},{"issue":"W1","key":"4816_CR102","doi-asserted-by":"publisher","first-page":"W322","DOI":"10.1093\/nar\/gkz397","volume":"47","author":"G Weng","year":"2019","unstructured":"Weng G. HawkDock: a web server to predict and analyse the protein-protein complex based on computational docking and MM\/GBSA. Nucleic Acids Res. 2019;47(W1):W322\u201330.","journal-title":"Nucleic Acids Res"},{"key":"4816_CR103","doi-asserted-by":"publisher","first-page":"W526","DOI":"10.1093\/nar\/gki376","volume":"33","author":"A Grote","year":"2005","unstructured":"Grote A, Hiller K, Scheer M, et al. JCat: A novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 2005;33:W526\u201331.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-04816-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-022-04816-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-04816-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T19:09:32Z","timestamp":1676315372000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-022-04816-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4816"],"URL":"https:\/\/doi.org\/10.1186\/s12859-022-04816-6","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for this work as no ethical clearance was needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"319"}}